| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BeiGene, Ltd. | Director | Ordinary Shares | 27.3K | $6.69M | $244.90 | May 21, 2025 | Direct |
| ALNYLAM PHARMACEUTICALS, INC. | Director | Common Stock | 775 | $181K | $232.95 | May 8, 2025 | Direct |
| Vaxcyte, Inc. | Director | Common Stock | 1.15K | $33.3K | $29.00 | Jun 12, 2025 | Direct |
| BeiGene, Ltd. | Director | Share Option (Right to Buy) | 22.8K | May 21, 2025 | Direct | ||
| Vaxcyte, Inc. | Director | Stock Option (right to buy) | 5.81K | Jun 12, 2025 | Direct | ||
| ALNYLAM PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 1.56K | May 8, 2025 | Direct | ||
| Vaxcyte, Inc. | Director | No securities owned. | 0 | May 1, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | Jun 12, 2025 | 2 | $0 | 4 | Jun 16, 2025 | Director |
| BGNE | BeiGene, Ltd. | May 21, 2025 | 2 | $0 | 4 | May 22, 2025 | Director |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | May 8, 2025 | 2 | $0 | 4 | May 12, 2025 | Director |
| PCVX | Vaxcyte, Inc. | May 1, 2025 | 1 | $0 | 4 | May 2, 2025 | Director |
| PCVX | Vaxcyte, Inc. | May 1, 2025 | 0 | $0 | 3 | May 2, 2025 | Director |
| BGNE | BeiGene, Ltd. | Jun 5, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Director |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | May 16, 2024 | 1 | $0 | 4 | May 20, 2024 | Director |
| BGNE | BeiGene, Ltd. | Feb 29, 2024 | 1 | $0 | 4 | Mar 4, 2024 | Director |
| BGNE | BeiGene, Ltd. | Jan 23, 2024 | 0 | $0 | 3 | Jan 23, 2024 | Director |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | May 18, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | May 18, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Jul 15, 2021 | 1 | $0 | 4 | Jul 19, 2021 | Director |